sb 203580 has been researched along with tyrphostin 25 in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (tyrphostin 25) | Trials (tyrphostin 25) | Recent Studies (post-2010) (tyrphostin 25) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 96 | 0 | 7 |
| Protein | Taxonomy | sb 203580 (IC50) | tyrphostin 25 (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 3 | |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | 3 | |
| Autoinducer 2-binding periplasmic protein LuxP | Vibrio harveyi | 3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauvois, B; Gogusev, J; Knapnougel, P; Nguyen, J | 1 |
1 other study(ies) available for sb 203580 and tyrphostin 25
| Article | Year |
|---|---|
Protein tyrosine kinase and p38 MAP kinase pathways are involved in stimulation of matrix metalloproteinase-9 by TNF-alpha in human monocytes.
Topics: Adult; Cell Adhesion; Cell Differentiation; Cell Survival; Cells, Cultured; Down-Regulation; Humans; I-kappa B Kinase; Imidazoles; Matrix Metalloproteinase 9; Middle Aged; Monocytes; p38 Mitogen-Activated Protein Kinases; Phenotype; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Protein-Tyrosine Kinases; Pyridines; Signal Transduction; Tissue Inhibitor of Metalloproteinase-1; Tumor Necrosis Factor-alpha; Tyrphostins | 2006 |